FIRST AMENDMENT to CLINICAL TRIAL COLLABORATION AGREEMENT between Idenix Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc.,Trial Collaboration Agreement • August 7th, 2013 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
This first Amendment (the “First Amendment”) to the Clinical Trial Collaboration Agreement (as defined below) shall be effective as of the last of the last signature affixed hereto (“First Amendment Effective Date”), and is entered into by and between Janssen Pharmaceuticals, Inc., having an address at 1125 Trenton-Harbourton Road, Titusville, New Jersey 08560, USA (hereinafter referred to as “Janssen”) and Idenix Pharmaceuticals, Inc., a Delaware corporation with a place of business at 60 Hampshire Street, Cambridge, MA 02139 (“Idenix”). Idenix and Janssen may be referred to herein individually as a “Party,” or collectively as the “Parties.”
FIRST AMENDMENT TO LEASELease • August 7th, 2013 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT TO LEASE (this “Amendment”) is entered into as of this 1st day of May, 2013, by and between BMR-ROGERS STREET LLC, a Delaware limited liability company (“Landlord”), and IDENIX PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
